Am J Psychiatry:抗抑郁治疗与工作效率研究

2016-08-25 Moon 译 MedSci原创

抑郁症又称抑郁障碍,以显著而持久的心境低落为主要临床特征,是心境障碍的主要类型。 抗抑郁药治疗试验中抑郁症状的严重程度是最常见的研究结果,与抑郁症有关的负担仅占一小部分。虽然失去工作效率是抑郁症患者经济负担的最大贡献者,但很少有研究系统地评估治疗对工作效率的独立影响,以及工作效率的变化和长期临床病程之间的关系。 通过工作效率和活动障碍的自我报告问卷重复测量331名参与者的工作效率,这些

抑郁症又称抑郁障碍,以显著而持久的心境低落为主要临床特征,是心境障碍的主要类型。

抗抑郁药治疗试验中抑郁症状的严重程度是最常见的研究结果,与抑郁症有关的负担仅占一小部分。虽然失去工作效率是抑郁症患者经济负担的最大贡献者,但很少有研究系统地评估治疗对工作效率的独立影响,以及工作效率的变化和长期临床病程之间的关系。

通过工作效率和活动障碍的自我报告问卷重复测量331名参与者的工作效率,这些参与者是结合药物治疗以改善抑郁症结局试验的主要抑郁症患者。识别了治疗过程中的第一个6周的工作效率变化轨迹,并用于预测3个月和7个月时的缓解。

参与者觉得进行抗抑郁药治疗后工作缺席情况减少了,工作效率提高了,校正抑郁症的严重程度变化后,这些情况仍存在。研究者发现了三种不同的工作效率变化轨迹:1.强大的早期改善(24%);2.最小改变(49%);3.高损伤轻微降低(27%)。与其他参与者相比,强大的早期改善患者3个月时缓解可能性高出3-5倍,7个月时缓解可能性高出2-5倍,校正基线变量和6周缓解状态后,情况仍如此。

二次分析数据表明,进行抗抑郁药治疗后患者的工作效率提高了。早期的工作效率改善与治疗3个月和7个月后更高的缓解率有关。

原始出处:

Jha MK, et al. Early Improvement in Work Productivity Predicts Future Clinical Course in Depressed Outpatients: Findings From the CO-MED Trial .Am J Psychiatry. 2016;doi:10.1176/appi.ajp.2016.16020176).

本文系梅斯医学(MedSci)原创编译整理,转载需授权 !更多资讯,请下载"辣眼睛的医学科 研神器之梅斯医学APP”!扫一下二维码即可:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1792011, encodeId=20571e9201174, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Tue May 16 16:37:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650951, encodeId=edd41650951b3, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 12 03:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951519, encodeId=af7719515195c, content=<a href='/topic/show?id=64ef5533e0d' target=_blank style='color:#2F92EE;'>#抗抑郁治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55337, encryptionId=64ef5533e0d, topicName=抗抑郁治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Wed Sep 14 08:37:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=112736, encodeId=6d32112e3620, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Sep 06 23:47:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492160, encodeId=11ae1492160cf, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Sat Aug 27 14:37:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1792011, encodeId=20571e9201174, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Tue May 16 16:37:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650951, encodeId=edd41650951b3, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 12 03:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951519, encodeId=af7719515195c, content=<a href='/topic/show?id=64ef5533e0d' target=_blank style='color:#2F92EE;'>#抗抑郁治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55337, encryptionId=64ef5533e0d, topicName=抗抑郁治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Wed Sep 14 08:37:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=112736, encodeId=6d32112e3620, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Sep 06 23:47:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492160, encodeId=11ae1492160cf, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Sat Aug 27 14:37:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1792011, encodeId=20571e9201174, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Tue May 16 16:37:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650951, encodeId=edd41650951b3, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 12 03:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951519, encodeId=af7719515195c, content=<a href='/topic/show?id=64ef5533e0d' target=_blank style='color:#2F92EE;'>#抗抑郁治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55337, encryptionId=64ef5533e0d, topicName=抗抑郁治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Wed Sep 14 08:37:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=112736, encodeId=6d32112e3620, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Sep 06 23:47:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492160, encodeId=11ae1492160cf, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Sat Aug 27 14:37:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1792011, encodeId=20571e9201174, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Tue May 16 16:37:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650951, encodeId=edd41650951b3, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 12 03:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951519, encodeId=af7719515195c, content=<a href='/topic/show?id=64ef5533e0d' target=_blank style='color:#2F92EE;'>#抗抑郁治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55337, encryptionId=64ef5533e0d, topicName=抗抑郁治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Wed Sep 14 08:37:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=112736, encodeId=6d32112e3620, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Sep 06 23:47:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492160, encodeId=11ae1492160cf, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Sat Aug 27 14:37:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]
    2016-09-06 李东泽

    很好,不错,以后会多学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1792011, encodeId=20571e9201174, content=<a href='/topic/show?id=696a14818df' target=_blank style='color:#2F92EE;'>#Psychiatry#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14818, encryptionId=696a14818df, topicName=Psychiatry)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c192448, createdName=diushouji, createdTime=Tue May 16 16:37:00 CST 2017, time=2017-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1650951, encodeId=edd41650951b3, content=<a href='/topic/show?id=82d74e8850d' target=_blank style='color:#2F92EE;'>#工作效率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47885, encryptionId=82d74e8850d, topicName=工作效率)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26da24104226, createdName=chenshujs, createdTime=Wed Oct 12 03:37:00 CST 2016, time=2016-10-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1951519, encodeId=af7719515195c, content=<a href='/topic/show?id=64ef5533e0d' target=_blank style='color:#2F92EE;'>#抗抑郁治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55337, encryptionId=64ef5533e0d, topicName=抗抑郁治疗)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c3a189, createdName=longqijun248, createdTime=Wed Sep 14 08:37:00 CST 2016, time=2016-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=112736, encodeId=6d32112e3620, content=很好,不错,以后会多学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzUn81b5CF5ibVPib8jWI92iciaxmqGHlwruOnK4SVZykd4iahqo1hicklIibyZoxm55X7EM8BW9eX1h1hQ2/0, createdBy=8aa81937526, createdName=李东泽, createdTime=Tue Sep 06 23:47:00 CST 2016, time=2016-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1492160, encodeId=11ae1492160cf, content=<a href='/topic/show?id=7999553333c' target=_blank style='color:#2F92EE;'>#抗抑郁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=55333, encryptionId=7999553333c, topicName=抗抑郁)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a59b8920619, createdName=wushaoling, createdTime=Sat Aug 27 14:37:00 CST 2016, time=2016-08-27, status=1, ipAttribution=)]

相关资讯

喜讯!强生潜在重磅抗抑郁药艾氯胺酮(esketamine)斩获FDA第2个突破性药物资格

美国医药巨头强生(JNJ)在研抗抑郁药物艾氯胺酮(esketamine)近日在美国监管方面传来喜讯。FDA已授予esketamine治疗伴有紧迫自杀风险的重度抑郁症的突破性药物资格(BTD)。值得一提的是,此次BTD,也标志着esketamine在美国监管方面收获的第二个BTD。之前,FDA已于2013年11月授予esketamine治疗药物难治性抑郁症的突破性药物资格。 抑郁症是一种与自杀倾向

JAMA Psychiatry:父母和/或祖父母患过抑郁症的儿童要小心了

根据JAMA Psychiatry在线发表的一项研究发现,父母和祖父母都患有重度抑郁症(MDD),则子孙患MDD的风险会增加,这一发现有助于识别那些可能受益于早期干预的患者。众所周知,父母有抑郁症会增加孩子精神障碍的风险。但目前还没有发表的抑郁症研究以直接访谈所有家庭成员的方式来探讨子孙三代抑郁症的风险。来自美国哥伦比亚大学和纽约州精神病研究所的Myrna M. Weissman博士,研究了251

PLoS One:抑郁症是12种心、脑、外周血管疾病的危险因素

背景:抑郁症与冠状动脉心脏疾病和卒中相关,但与一系列的病理不同的心血管疾病的相关性还没有很好的研究。研究者根据抑郁症的状态,研究了12种心血管疾病的风险(历史或新发病的)。方法: 使用英国电子健康记录在1997和2010之间,基线时无心血管疾病的1937360名成年男性和女性的队列研究。暴露是新发的抑郁症(新诊断的抑郁症和/或在基线一年内应用抗抑郁药),以及基线前诊断为抑郁症。主要终点是基线后12

Stroke:中国人群中,抑郁症的存在是卒中的危险因素

虽然以往的研究已经探讨了抑郁症和卒中风险之间的关系,但其报告中的调查结果是相互矛盾的。这项研究的目的是前瞻性探讨重大抑郁发作(MDE)对卒中的影响,并进一步评估在中国人群中,抑郁症状数量和随后卒中风险之间潜在的剂量-反应关系。中国嘉道理生物库队列研究共纳入199294名男性和288083名女性,这些参与者年龄在30岁至79岁,并且无卒中,心脏疾病和癌症史,从2004年到2013年接受随访。根据诊断

迷幻蘑菇药物有望治疗抑郁症

伦敦帝国理工学院的研究人员让12名受试者服用了裸盖菇素,后者是迷幻蘑菇中的一种活性成分。所有这些受试者在临床上都有很长时间的抑郁症患病史——平均17.8年。同时所有患者对于抑郁症标准疗法都没有响应,例如选择性血清素再吸收抑制剂(SSRIs)或电休克疗法。在接受了口服剂量的裸盖菇素1周后,所有患者的症状都得到了显著改善。3个月后,其中5位患者得到了完全缓解。研究人员在最新出版的《柳叶刀—精神病学》杂

Lancet:行为激活疗法可更经济的治疗抑郁症,且效果不输于CBT

抑郁症是一种常见的疾病,逐渐削弱患者的身体素质,且治疗十分昂贵。许多患者需要接受心理治疗,但是使用目前证明疗效最好的认知行为疗法(CBT)治疗时过程十分复杂且费用昂贵。一个简单的疗法——行为激活(BA)-或与CBT一样有效,且更便宜。本研究旨在治疗成人抑郁症时与CBT相比建立BA的临床疗效和成本效益。在此随机、对照、非劣效性试验中,研究人员招募18岁及以上的抑郁症成年患者,排除了接受心理治疗,酒精